Efficacy and safety of exenatide administered before the two largest daily meals of Latin American patients with type 2 diabetes

References

• Arauz-Pacheco C, Clements G, Cercone S. et al. Effects of a large supper on glucose levels the following morning in patients with type 2 diabetes. J Diabetes Complications 1998;12:61–41. Arauz-Pacheco C, Clements G, Cercone S. et al. Effects of a large supper on glucose levels the following morning in patients with type 2 diabetes. J Diabetes Complications 1998;12:61–4
   PubMed Web of Science ®Google Scholar
• Chen HS, Jap TS, Chen RL. et al. A prospective study of glycemic control during holiday time in type 2 diabetic patients. Diabetes Care 2004;27:326–302. Chen HS, Jap TS, Chen RL. et al. A prospective study of glycemic control during holiday time in type 2 diabetic patients. Diabetes Care 2004;27:326–30
   PubMed Web of Science ®Google Scholar
• Grivetti LE. Morning meals: North American and Mediter-ranean breakfast patterns Part 3: Mediterranean patterns and summary. Nutrition Today 1997;32:164–713. Grivetti LE. Morning meals: North American and Mediter-ranean breakfast patterns Part 3: Mediterranean patterns and summary. Nutrition Today 1997;32:164–71
   Google Scholar
• Grivetti LE. Morning meals: North American and Mediter-ranean breakfast patterns Part 2: America at Breakfast. Nutrition Today 1995;30:128–344. Grivetti LE. Morning meals: North American and Mediter-ranean breakfast patterns Part 2: America at Breakfast. Nutrition Today 1995;30:128–34
   Google Scholar
• Grivetti LE. Morning meals: North American and Mediter-ranean breakfast patterns. The European Anglo-Saxon Heritage. Nutrition Today 1995;30:24–95. Grivetti LE. Morning meals: North American and Mediter-ranean breakfast patterns. The European Anglo-Saxon Heritage. Nutrition Today 1995;30:24–9
   Google Scholar
• Kolterman OG, Buse JB, Fineman MS. et al. Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab 2003;88:3082–96. Kolterman OG, Buse JB, Fineman MS. et al. Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab 2003;88:3082–9
   PubMed Web of Science ®Google Scholar
• Heine RJ, Van Gaal LF, Johns D. et al. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med 2005;143:559–697. Heine RJ, Van Gaal LF, Johns D. et al. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med 2005;143:559–69
   PubMed Web of Science ®Google Scholar
• Nauck MA, Duran S, Kim D. et al. A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 2007;50:259–678. Nauck MA, Duran S, Kim D. et al. A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 2007;50:259–67
   PubMed Web of Science ®Google Scholar
• Barnett AH, Burger J, Johns D. et al. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial. Clin Ther 2007;29:2333–489. Barnett AH, Burger J, Johns D. et al. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial. Clin Ther 2007;29:2333–48
   PubMed Web of Science ®Google Scholar
• World Medical Association General Assembly. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Nurs Ethics 2002;9:105–910. World Medical Association General Assembly. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Nurs Ethics 2002;9:105–9
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. 1996 Guidance for Industry. E6 Good Clinical Practice: Consolidated Guidance11. US Department of Health and Human Services. 1996Guidance for Industry. E6 Good Clinical Practice: Consolidated Guidance
   Google Scholar
• Buse JB, Henry RR, Han J. et al. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care 2004;27:2628–3512. Buse JB, Henry RR, Han J. et al. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care 2004;27:2628–35
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Ratner RE, Han J. et al. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 2005;28:1092–10013. DeFronzo RA, Ratner RE, Han J. et al. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 2005;28:1092–100
   PubMed Web of Science ®Google Scholar
• Kendall DM, Riddle MC, Rosenstock J. et al. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care 2005;28:1083–9114. Kendall DM, Riddle MC, Rosenstock J. et al. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care 2005;28:1083–91
   PubMed Web of Science ®Google Scholar
• Zinman B, Hoogwerf BJ, Duran GS. et al. The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med 2007;146:477–8515. Zinman B, Hoogwerf BJ, Duran GS. et al. The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med 2007;146:477–85
   PubMed Web of Science ®Google Scholar
• Klonoff DC, Buse JB, Nielsen LL. et al. Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. Curr Med Res Opin 2008;24:275–8616. Klonoff DC, Buse JB, Nielsen LL. et al. Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. Curr Med Res Opin 2008;24:275–86
   PubMed Web of Science ®Google Scholar
• Bacardi-Gascon M, Duenas-Mena D, Jimenez-Cruz A. Lowering effect on postprandial glycemic response of nopales added to Mexican breakfasts. Diabetes Care 2007;30:1264–517. Bacardi-Gascon M, Duenas-Mena D, Jimenez-Cruz A. Lowering effect on postprandial glycemic response of nopales added to Mexican breakfasts. Diabetes Care 2007;30:1264–5
   PubMed Web of Science ®Google Scholar
• Bornet FR, Costagliola D, Rizkalla SW. et al. Insulinemic and glycemic indexes of six starch-rich foods taken alone and in a mixed meal by type 2 diabetics. Am J Clin Nutr 1987;45:588–9518. Bornet FR, Costagliola D, Rizkalla SW. et al. Insulinemic and glycemic indexes of six starch-rich foods taken alone and in a mixed meal by type 2 diabetics. Am J Clin Nutr 1987;45:588–95
   PubMed Web of Science ®Google Scholar
• Anderson JW, Randles KM, Kendall CW. et al. Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr 2004;23:5–1719. Anderson JW, Randles KM, Kendall CW. et al. Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr 2004;23:5–17
   PubMed Web of Science ®Google Scholar
• Bermudez OI, Tucker KL. Trends in dietary patterns of Latin American populations. Cad Saude Publica 2003;19 Suppl 1:S87–S9920. Bermudez OI, Tucker KL. Trends in dietary patterns of Latin American populations. Cad Saude Publica 2003;19 Suppl 1:S87–S99
   PubMedGoogle Scholar